sj-docx-1-cat-10.1177_10760296231177017 - Supplemental material for Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

Supplemental material, sj-docx-1-cat-10.1177_10760296231177017 for Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study by Khalid Al Sulaiman, MBA, BCCCP, BCNSP, FCCM, Ohoud Aljuhani, PharmD, Ghazwa B. Korayem, PharmD, Lina I. Alnajjar, PharmD, Ali F. Altebainawi, PharmD, Mashael AlFaifi, PharmD, Ramesh Vishwakarma, PhD, Abeer A. Alenazi, PharmD, Mai Alalawi, PharmD, Abdulrahman Alissa, PharmD, Yazed S. Alsowaida, BSc, PharmD, Samiah Alsohimi, PharmD, Alaa Almagthali, PharmD, Saeed M. Alay, PharmD, Noora Altaher, PharmD, Mohammed G. Alamri, PharmD, Dalal Alangari, PharmD, Amer Alzahrani, MD, Habeeb Ibrahim Abdul Razack, MPharm, MSc CRRA, Jwael Alhamoud, BSc, Abdulrahman Alshaya, PharmD, Jawaher Gramish, PharmD, Kholoud Al Aamer, MSc, Alawi S. Alsaeedi, MD, and Ghassan Alghamdi, MD in Clinical and Applied Thrombosis/Hemostasis